Apple Watch AFib feature gets new FDA seal of approval

The Apple Watch's AFib detection feature, which identifies irregular heartbeats indicative of atrial fibrillation, has received enhanced approval from the FDA. Previously granted a basic clearance, the feature is now recognized under the FDA's Medical Device Development Tool (MDDT) program. This new qualification allows researchers to use the Apple Watch data in clinical studies to assess atrial fibrillation severity and treatment efficacy, marking a significant advancement in its medical utility.